Literature DB >> 17515836

Peroxynitrite decomposition catalyst FeTMPyP provides partial protection against intestinal ischemia and reperfusion injury in infant rats.

Giorgio Stefanutti1, Agostino Pierro, Virpi V Smith, Nigel J Klein, Simon Eaton.   

Abstract

Free radicals are important in development of intestinal ischemia-reperfusion (I/R) injury, leading to intestinal and pulmonary damage. We evaluated the effects of peroxynitrite decomposition catalyst FeTMPyP in infant intestinal I/R. Suckling rats underwent 40 min intestinal ischemia + 90 min reperfusion. At reperfusion, animals received saline or FeTMPyP. Groups were (n = 11 per group): 1) control+saline; 2) I/R+saline; 3) I/R+FeTMPyP. Increased histologic injury and ICAM-1 expression were observed in ileum of both I/R+saline and I/R+FeTMPyP rats, but P-selectin expression was increased in I/R+saline animals only versus controls. Myeloperoxidase (neutrophil infiltration marker) was increased in ileum and lungs of I/R+saline rats, but FeTMPyP prevented this in the ileum. I/R+saline animals showed higher malondialdehyde (lipid peroxidation marker) in ileum and lungs versus both control+saline and I/R+FeTMPyP rats. Glutathione was decreased in all I/R animals, but oxidized and total glutathione were higher in I/R+FeTMPyP than the I/R+saline group. Nitrate+nitrite concentration (systemic nitric oxide production) was elevated in I/R+saline but not in I/R+FeTMPyP animals. FeTMPyP provides limited protection against intestinal I/R in neonatal rats by reducing ileal P-selectin expression, systemic nitric oxide production, neutrophil infiltration in ileum and lipid peroxidation in both lungs and ileum; and preserving intestinal antioxidant capacity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17515836     DOI: 10.1203/PDR.0b013e31806790c0

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  9 in total

Review 1.  Pathophysiological roles of peroxynitrite in circulatory shock.

Authors:  Csaba Szabó; Katalin Módis
Journal:  Shock       Date:  2010-09       Impact factor: 3.454

Review 2.  Pharmacological antioxidant strategies as therapeutic interventions for COPD.

Authors:  Irfan Rahman
Journal:  Biochim Biophys Acta       Date:  2011-11-09

3.  Peroxynitrite decomposition catalyst prevents matrix metalloproteinase activation and neurovascular injury after prolonged cerebral ischemia in rats.

Authors:  Yalikun Suofu; Joseph Clark; Joseph Broderick; Kenneth R Wagner; Thomas Tomsick; Yalian Sa; Aigang Lu
Journal:  J Neurochem       Date:  2010-10-26       Impact factor: 5.372

4.  [Evaluation of renal tissue ischemia-reperfusion injury with ultrasound radiation force and targeted microbubbles].

Authors:  Bao-Ping Wang; Li-Hong Luo; Feng-Lin Wu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-03-20

Review 5.  Strategies to decrease ongoing oxidant burden in chronic obstructive pulmonary disease.

Authors:  Irfan Rahman; Vuokko L Kinnula
Journal:  Expert Rev Clin Pharmacol       Date:  2012-05       Impact factor: 5.045

6.  Differential patterns of peroxynitrite mediated apoptosis in proximal tubular epithelial cells following ATP depletion recovery.

Authors:  Vani Nilakantan; Huanling Liang; Cheryl J Maenpaa; Christopher P Johnson
Journal:  Apoptosis       Date:  2008-05       Impact factor: 4.677

Review 7.  Superoxide dismutase mimics: chemistry, pharmacology, and therapeutic potential.

Authors:  Ines Batinić-Haberle; Júlio S Rebouças; Ivan Spasojević
Journal:  Antioxid Redox Signal       Date:  2010-09-15       Impact factor: 8.401

Review 8.  SOD therapeutics: latest insights into their structure-activity relationships and impact on the cellular redox-based signaling pathways.

Authors:  Ines Batinic-Haberle; Artak Tovmasyan; Emily R H Roberts; Zeljko Vujaskovic; Kam W Leong; Ivan Spasojevic
Journal:  Antioxid Redox Signal       Date:  2013-10-01       Impact factor: 8.401

Review 9.  Oxidative stress and free radicals in COPD--implications and relevance for treatment.

Authors:  Wolfgang Domej; Karl Oettl; Wilfried Renner
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-10-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.